Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of the American Association of Nurse Practitioners
|
April 14, 2020
Transitioning to non-insulin therapy in a patient receiving high dose insulin
Basem M Mishriky, Doyle M Cummings, Carlos E Mendez, et al.
Applied Nursing Research : ANR
|
June 2, 2018
Factors associated with physical activity in African Americans with hypertension
Linda P Bolin, Patricia B Crane, James R Powell, et al.
Diabetes, Obesity & Metabolism
|
June 7, 2019
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta-analysis
Basem M Mishriky, James R Powell, Jennifer A Wittwer, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 19, 2017
Integrated Microarray-based Tools for Detection of Genomic DNA Damage and Repair Mechanisms
Patrick van Eijk, Yumin Teng, Mark R Bennet, et al.
Leukemia & Lymphoma
|
October 2, 2012
Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab
James R Powell, Stefan Dojcinov, Louise King, et al.
Journal of Clinical Pharmacology
|
May 13, 2020
Should Baseline Hemoglobin A<sub>1c</sub> or Dose of SGLT-2i Guide Treatment With SGLT-2i Versus DPP-4i in People With Type 2 Diabetes? A Meta-Analysis and Systematic Review
Jarrod L Uhrig, Stephanie O Page, Basem M Mishriky, et al.
Journal of the American Geriatrics Society
|
November 29, 2019
Impact of Intensive Blood Pressure Therapy on Concern about Falling: Longitudinal Results from the Systolic Blood Pressure Intervention Trial (SPRINT)
Dan R Berlowitz, Capri Foy, Molly Conroy, et al.
Diabetes, Obesity & Metabolism
|
February 16, 2024
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data
Basem M Mishriky, Doyle M Cummings, Yuanyuan Fu, et al.
Journal of the American Geriatrics Society
|
September 20, 2016
Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention Trial
Dan R Berlowitz, Tonya Breaux-Shropshire, Capri G Foy, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
January 13, 2016
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial
Nicholas M Pajewski, Jeff D Williamson, William B Applegate, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of the American Association of Nurse Practitioners
|
April 14, 2020
Transitioning to non-insulin therapy in a patient receiving high dose insulin
Basem M Mishriky, Doyle M Cummings, Carlos E Mendez, et al.
Applied Nursing Research : ANR
|
June 2, 2018
Factors associated with physical activity in African Americans with hypertension
Linda P Bolin, Patricia B Crane, James R Powell, et al.
Diabetes, Obesity & Metabolism
|
June 7, 2019
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta-analysis
Basem M Mishriky, James R Powell, Jennifer A Wittwer, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 19, 2017
Integrated Microarray-based Tools for Detection of Genomic DNA Damage and Repair Mechanisms
Patrick van Eijk, Yumin Teng, Mark R Bennet, et al.
Leukemia & Lymphoma
|
October 2, 2012
Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab
James R Powell, Stefan Dojcinov, Louise King, et al.
Journal of Clinical Pharmacology
|
May 13, 2020
Should Baseline Hemoglobin A<sub>1c</sub> or Dose of SGLT-2i Guide Treatment With SGLT-2i Versus DPP-4i in People With Type 2 Diabetes? A Meta-Analysis and Systematic Review
Jarrod L Uhrig, Stephanie O Page, Basem M Mishriky, et al.
Journal of the American Geriatrics Society
|
November 29, 2019
Impact of Intensive Blood Pressure Therapy on Concern about Falling: Longitudinal Results from the Systolic Blood Pressure Intervention Trial (SPRINT)
Dan R Berlowitz, Capri Foy, Molly Conroy, et al.
Diabetes, Obesity & Metabolism
|
February 16, 2024
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data
Basem M Mishriky, Doyle M Cummings, Yuanyuan Fu, et al.
Journal of the American Geriatrics Society
|
September 20, 2016
Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention Trial
Dan R Berlowitz, Tonya Breaux-Shropshire, Capri G Foy, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
January 13, 2016
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial
Nicholas M Pajewski, Jeff D Williamson, William B Applegate, et al.
Page
of 3